BioSpace News Archive

Researchers from Children’s Hospital of Philadelphia found that while autism screening rates during the first year of the COVID-19 pandemic may not have dropped sharply, many routine screenings may have been missed due to routine well-child visits being canceled and postponed.

According to QY Research Medical, the membrane microfiltration market size was surpassed at $3,772.70 million in 2020, and is expected to reach $8,849.50 million by 2030, growing at a CAGR of 8.9% from 2021 to 2030.

MOBILion Systems Inc. is teaming up with its industry partners, including Agilent Technologies and Protein Metrics, to deliver a series of educational events at the 70th Annual American Society for Mass Spectrometry conference being held June 5th to June 9th in Minneapolis, Minnesota.

The global ostomy drainage bags market is expected to witness growth at a CAGR of 4% from 2021 to 2030 and to reach $2,409.38 million by 2030.

G1 Therapeutics, Inc. (Nasdaq: GTHX), today announced results of a post-hoc study analysis showing that ES-SCLC patients who received trilaciclib prior to chemotherapy had a lower incidence of single- and multilineage myelosuppressive events—fewer cases of severe neutropenia, severe anemia, and severe thrombocytopenia—compared to patients receiving placebo.

A breakdown in how brain cells rid themselves of waste precedes the buildup of debris-filled plaques known to occur in Alzheimer’s disease, a new study in mice shows.

According to QY Research Medical, the refurbished DNA sequencing platforms market size was estimated at $89.83 million in 2020, and is expected to reach $129.61 million by 2030, registering a CAGR of 2.6% from 2021 to 2030.

Immunicom, Inc., a privately held clinical-stage biotechnology company with a transformative immuno-oncology platform, presented data from its ongoing clinical investigation [NCT04004910] at the American Society of Clinical Oncology’s (ASCO) 2022 Annual Meeting.

LianBio, a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, announced that members of the management team will participate in fireside chats at the following upcoming investor conferences.

Supernus Pharmaceuticals, Inc. announced that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will present at the Jefferies Healthcare Conference on Thursday, June 9, 2022, at 10:30 a.m. ET.